|
|
 |
Editor(s)
P. Leif Bergsagel, MD
Professor of Medicine, Consultant
Mayo Clinic
Scottsdale, Arizona
P. Leif Bergsagel, MD is a professor of medicine and consultant at the Mayo Clinic in Scottsdale, Arizona. Dr Bergsagel received his medical degree from the University of Toronto. He completed his internship and residency at Sunnybrook Medical Center, Toronto followed by a fellowship in medical oncology at the National Cancer Institute, Bethesda, Maryland.
Dr Bergsagel’s research focuses on the molecular pathogenesis of multiple myeloma, and he serves as principal investigator for several active research grants and clinical trials. Dr Bergsagel is a manuscript reviewer for numerous journals including the New England Journal of Medicine, The Journal of Experimental Medicine, the Journal of Immunology, and Blood. Dr Bergsagel has published extensively in top-tier peer-reviewed journals, and has written several book chapters, editorials, abstracts, and letters.
Harry P. Erba, MD, PhD
Associate Professor of Internal Medicine
University of Michigan Medical School
Ann Arbor, Michigan
Harry P. Erba, MD, PhD is associate professor of internal medicine at the University of Michigan Medical School in Ann Arbor, Michigan. Dr Erba earned his medical degree and doctoral degree in biophysics from Stanford University School of Medicine in Stanford, California. He completed his residency and clinical fellowship in internal medicine at Brigham and Women’s Hospital and his research fellowship in medicine at Harvard Medical School in Boston, Massachusetts.
Dr Erba is an executive officer of the Southwest Oncology Group, and is principal investigator or co-investigator on several clinical protocols. His clinical research focuses on the development of novel therapies for older patients with acute myeloid leukemia and myelodysplastic syndromes.
Dr Erba serves on the National Comprehensive Cancer Network Practice Guidelines Committees for acute myeloid leukemia, chronic myeloid leukemia, and myelodysplastic syndromes. He has lectured extensively, both nationally and internationally, and has published numerous peer-reviewed manuscripts, book chapters, review articles, and research abstracts. In recognition of his clinical and teaching skills, Dr Erba has received many honors, including the University of Michigan’s 2004 Outstanding Clinician Award and 2002, 2003, 2004, and 2005 Teacher of the Year.
Christopher R. Flowers, MD, MSc
Assistant Professor, Hematology and Oncology
Winship Cancer Institute
Emory University School of Medicine
Adjunct Assistant Professor
School of Industrial and Systems Engineering
Georgia Institute of Technology
Atlanta, Georgia
Christopher R. Flowers, MD, MSc is an assistant professor of hematology and oncology at Winship Cancer Institute at the Emory University School of Medicine and an adjunct assistant professor at the School of Industrial and Systems Engineering at Georgia Institute of Technology. Dr Flowers is director of the Emory Lymphoma Program and is a member of the Emory stem cell and bone marrow transplant team.
Dr Flowers received his undergraduate degree, MD, and MSc from Stanford University. He completed his internal medicine residency at the University of Washington and then continued his research training through the University of Washington Robert Wood Johnson Clinical Scholars Program and oncology fellowship at the Fred Hutchinson Cancer Research Center.
Through the lymphoma program, Dr Flowers offers a variety of clinical trials and advanced treatment algorithms for patients with lymphoma. His current research spans three areas: 1) translational research and clinical trials in non-Hodgkin Lymphoma, 2) oncology informatics projects developing an information infrastructure to support pharmacogenomics and outcomes research, and 3) medical decision analyses aimed at developing strategies to individualize care for cancer patients.
Dr Flowers was the recipient of the Amos Faculty Development Award from the American Society of Hematology/Robert Wood Johnson Foundation and the Distinguished Cancer Clinicians and Scientists Award from the Georgia Cancer Coalition.
Edward S. Kim, MD
Associate Professor of Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Edward S. Kim, MD is an associate professor of medicine in the Department of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. He also holds the position of chief, Section of Head and Neck Medical Oncology and serves as the director of Clinical Research Operations in the department.
Dr Kim received his bachelor of science and medical degrees from the Honors Program in Medical Education at Northwestern University in Chicago, Illinois, 1996. Dr Kim completed an internship and residency in internal medicine at the Baylor College of Medicine in Houston, Texas, 1996-1999, and his fellowship in medical oncology at The University of Texas MD Anderson Cancer Center, 1999-2001.
Dr Kim serves as principal investigator on numerous clinical studies including the Department of Defense Biomarker-based Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) or personalized medicine program in lung cancer. Dr Kim studies novel targeted agents in the treatment and prevention settings and has expertise in lung, head and neck, as well as thymic cancers.
Dr Kim is a member of numerous associations and societies, including ASCO, AACR, SWOG, and the Texas Medical Society. Dr Kim is also the recipient of several awards including the Young Investigators Award from ASCO in 2002, the Merit Award from ASCO in 2002, and the Scholar in Training Award from AACR in 2002.
Dr Kim is the author or coauthor of more than 100 published articles, book chapters, reviews, and abstracts in journals such as Lancet, Journal of Clinical Oncology, Cancer, and Cancer Prevention Research, involving cancer therapeutics and prevention with chemotherapy and novel targeted agents, with particular emphases on lung cancer and head and neck cancer.
|
|
|